Across TCGA pan-cancer cohorts, LINC02654 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated LINC02654 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02654 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02654 expression acts as an unfavorable survival marker.
LUAD, KIRP, and LAML are the cancer types where LINC02654 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.